Angiogenesis
Showing 1 - 25 of 2,813
Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)
Completed
- Angiogenesis
- Endometriosis
- Leuprolide Acetate
-
Patra, Peloponnese, Greece
- +1 more
Oct 27, 2023
ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced
Completed
- NSCLC
- Immune checkpoint inhibitors plus angiogenesis inhibitors
- Immune checkpoint inhibitors without angiogenesis inhibitors
-
Suzhou, Jiangsu, ChinaThe Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023
Covid19, Angiogenesis, Endothelial Dysfunction Trial in Independencia (Endothelial damage and angiogenic biomarkers)
Completed
- Covid19
- +3 more
- Endothelial damage and angiogenic biomarkers
-
Independencia, Santiago, ChileHospital Clínico de la Universidad de Chile
Jan 5, 2023
Peripheral Artery Disease Trial in Beijing (NL003, Placebo)
Recruiting
- Peripheral Artery Disease
- NL003
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Wounds Trial (VAC® Therapy System)
Withdrawn
- Wounds
- VAC® Therapy System
- (no location specified)
Jul 29, 2022
Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Advanced
Not yet recruiting
- Carcinoma, Hepatocellular
- (no location specified)
May 16, 2022
Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced
Recruiting
- Esophageal Neoplasms
- an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Apr 21, 2022
Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NODAGA-E[c(RGDyK)]2, PET/CT)
Completed
- Neuroendocrine Tumors
- One injection of 68Ga-NODAGA-E[c(RGDyK)]2
- PET/CT
-
Copenhagen, DenmarkDepartment of Clinical Physiology, Nuclear Medicine and PET, Rig
Jun 28, 2022
CD34 + Stem Cells and Biological Markers of Angiogenesis in
Recruiting
- Vasculopathy
- Heart Transplant Failure
- coronary CT angiography
-
Ljubljana, SloveniaAdvanced Heart Failure and Transplantation Center, University Me
Aug 2, 2022
Myocardial Infarction, Acute, Myocardial Reperfusion, Chronic Ischemic Heart Disease Trial in Lausanne (68Ga-NODAGA-RGD PET/CT,
Recruiting
- Myocardial Infarction, Acute
- +2 more
- 68Ga-NODAGA-RGD PET/CT
- 82-Rb PET/CT as part of standard care, not a comparator
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois
Jun 11, 2022
Von Willebrand Factor and Its Multimers on Angiogenesis
Not yet recruiting
- Von Willebrand Diseases
- no intervention
-
Nantes, FranceCHU de Nantes
Feb 17, 2022
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride
Not yet recruiting
- Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
- Anlotinib Hydrochloride Capsule and Penpulimab
-
Beijing, Beijing, ChinaYansongLin
Sep 25, 2023
NSCLC Trial in Tianjin (Tislelizumab, Pemetrexed, Bevacizumab)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Tislelizumab
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 11, 2022
Coronary Artery Disease Trial in Houston (Stem Cell Therapy, Control (plasma))
Active, not recruiting
- Coronary Artery Disease
- Stem Cell Therapy
- Control (plasma)
-
Houston, TexasTexas Heart Institute/Baylor St. Luke's Medical Center
Apr 25, 2022
Blood Flow MRI for Monitoring Brain Tumors
Active, not recruiting
- Brain Tumors
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 26, 2023
Pathophysiology of Paget's Disease of Bone
Active, not recruiting
- Paget's Disease of Bone
-
Baltimore, MarylandJohns Hopkins University
Oct 27, 2022
Therapeutic Combination in Advanced or Metastatic Kidney Cancer
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Blood collection
- Tumour samples
-
Paris, France
- +1 more
Mar 9, 2022
Biomarkers and Preeclampsia Outcomes
Completed
- Preeclampsia
-
Tunis, TunisiaMaternity Center of Tunis
Aug 19, 2022
Hematuria, Bladder Cancer Trial in Syracuse (Valproic Acid)
Completed
- Hematuria
- Bladder Cancer
- Valproic Acid
-
Syracuse, New YorkSUNY Upstate Medical University
Oct 19, 2021
Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)
Not yet recruiting
- Small Cell Lung Cancer
- +2 more
- (no location specified)
Nov 27, 2022
Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic
Terminated
- Ovarian Cancer
- +21 more
- Exercise Counseling
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 6, 2022
Muscle Weakness, Angiogenesis Trial in Taipei (Interactive Hand Exercise Game, Soft ball exercise ( routine care))
Not yet recruiting
- Muscle Weakness
- Angiogenesis
- Interactive Hand Exercise Game
- Soft ball exercise ( routine care)
-
Taipei, TaiwanHsiao-Yean Chiu
Aug 8, 2022
Type 2 Diabetes Trial in Marseille (Liraglutide, Metformin or sulfonylurea)
Completed
- Type 2 Diabetes
- Liraglutide
- Metformin or sulfonylurea
-
Marseille, FranceNutrition department, pole ENDO - Assistance Publique Hôpitaux M
Jun 14, 2021